Needham analyst David Saxon maintained a Hold rating on ZimVie Inc (ZIMV – Research Report) today. The company’s shares opened today at $14.24.
Saxon covers the Healthcare sector, focusing on stocks such as Cooper Co, Staar Surgical, and Glaukos. According to TipRanks, Saxon has an average return of 2.0% and a 40.38% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for ZimVie Inc with a $10.00 average price target.
See Insiders’ Hot Stocks on TipRanks >>
ZIMV market cap is currently $297.7M and has a P/E ratio of -3.32.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
ZimVie Inc (ZIMV) Company Description:
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions.
Read More on ZIMV:
- ZimVie announce compatibility between Vital, Brainlab Spine & Trauma Navigation
- ZimVie initiated with a Hold at Needham
- ZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual Guidance
- ZimVie announces first U.S. surgery with 4.5mm Mobi-C Cervical Disc
- ZimVie announces over 2,000 children have received The Tether VBT
